Work

Pharmacodynamics of the S1P1 receptor modulator cenerimod in a phase 2b randomised clinical trial in patients with moderate to severe SLE.

Year: 2024

Type: article

Source: PubMed

DOI: 10.1136/ard-2024-226547

Authors: Madeleine Suffiotti, Pijus Brazauskas, Marcel Peter Keller, Ouali Berkani, Gustavo Seifer, Peter Cornelisse, Mark Joseph Murphy, Daniel Stefan Strasser

Institutions: Idorsia Pharmaceuticals Ltd (Switzerland), Viatris

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404707497

FWCI: 0.822

Cites:

Cited by: 3

Related to: 10